MicroRNA 144 Impairs Insulin Signaling in Type 2 Diabetes
Author Information
Author(s): Karolina Dwi Setyowati, Armugam Arunmozhiarasi, Tavintharan Subramaniam, Wong Michael T. K., Lim Su Chi, Sum Chee Fang, Jeyaseelan Kandiah
Primary Institution: National University of Singapore
Hypothesis
The study investigates the role of circulating microRNAs, particularly miR-144, as biomarkers and regulators in Type 2 Diabetes Mellitus.
Conclusion
The study identifies miR-144 as a significant modulator of insulin receptor substrate 1 (IRS1), suggesting its potential as a biomarker for Type 2 Diabetes.
Supporting Evidence
- miR-144 was found to be highly up-regulated in Type 2 Diabetes patients.
- Increased levels of circulating miR-144 correlated with decreased IRS1 expression.
- miR-144 directly targets IRS1, inhibiting its expression.
- Eight miRNAs were identified as potential biomarkers for distinguishing between impaired fasting glucose and Type 2 Diabetes.
Takeaway
This study found that a tiny molecule called miR-144 can make it harder for the body to use insulin, which is important for controlling blood sugar levels.
Methodology
The study used miRNA microarray and stem-loop real-time RT-PCR to analyze miRNA expression in blood and tissues from Type 2 Diabetes rat models and human patients.
Potential Biases
Potential bias in participant selection as all subjects were not on any medications and were newly diagnosed.
Limitations
The study primarily focused on male participants and may not be generalizable to females or other populations.
Participant Demographics
The study included 50 male participants with a mean age of 40.5 years, categorized into healthy controls, impaired fasting glucose, and Type 2 Diabetes groups.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website